Literature DB >> 28199183

mRNA-miRNA integrative analysis of diabetes-induced cardiomyopathy in rats.

Mariana B Lopes1, Renata C Freitas1, Mario H Hirata2, Rosario Hirata2, Adriana A Rezende1, Vivian N Silbiger1, Raul H Bortolin1, Andre D Luchessi3.   

Abstract

An integrative analysis of miRNA and mRNA expression profiles in left ventricle (LV) of diabetes-induced rats was performed to elucidate the role of miRNAs and their mRNAs target in diabetic cardiomyopathy (DCM). mRNA (GSE4745) and miRNA (GSE44179) datasets were downloaded from Gene Expression Omnibus 2R (GEO2R) and differentially expressed mRNAs and miRNAs were selected. Cardiotoxicity-related mRNAs (n=7) were analyzed by Ingenuity Pathway Analyses 6 (IPA) and regulatory miRNAs (n=639) were identified using TargetScan 7.1. web dataset. The integrative analysis was performed between miRNAs differentially expressed in GSE44179 and regulatory TargetScan-detected miRNAs of mRNAs differentially expressed in GSE4745. Pla2g2a and Hk2 mRNAs were up-and-down regulated, respectively, in GSE4745 on days 3 and 42 after diabetes-induction. The Pla2g2a regulatory miRNAs, rno-miR-877, rno-miR-320 and rno-miR-214, were down-regulated, and Hk2 regulatory miRNAs, rno-miR-17, rno-miR-187, rno-miR-34a, rno-miR-322, rno-miR-188, rno-miR-532 and rno-miR-21, were up-regulated in GSE44179 dataset. These results are suggestive that Pla2g2a and Hk2 mRNAs and their regulatory miRNAs play a role in DCM pathogenesis and they may be potential circulating biomarkers to detect early cardiovascular complications in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28199183     DOI: 10.2741/s483

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  5 in total

1.  miR-126 targeting GOLPH3 inhibits the epithelial-mesenchymal transition of gastric cancer BGC-823 cells and reduces cell invasion.

Authors:  Jiancai Ouyang; Fuhu Song; He Li; Rui Yang; Haicheng Huang
Journal:  Eur J Histochem       Date:  2020-10-28       Impact factor: 3.188

2.  Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart.

Authors:  Xiaochen Li; Cheng Meng; Fei Han; Juhong Yang; Jingyu Wang; Yanjuan Zhu; Xiao Cui; Minxia Zuo; Jie Xu; Baocheng Chang
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

3.  Human Glucagon Expression Is under the Control of miR-320a.

Authors:  SeongHo Jo; Guanlan Xu; Gu Jing; Junqin Chen; Anath Shalev
Journal:  Endocrinology       Date:  2021-03-01       Impact factor: 5.051

4.  MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.

Authors:  Beibei Dai; Huaping Li; Jiahui Fan; Yanru Zhao; Zhongwei Yin; Xiang Nie; Dao Wen Wang; Chen Chen
Journal:  Cardiovasc Diabetol       Date:  2018-09-04       Impact factor: 9.951

Review 5.  Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection.

Authors:  Branislav Kura; Barbora Kalocayova; Yvan Devaux; Monika Bartekova
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.